Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells
The Spine Journal · 2023-10 · 23 (10) · 1549-1562
DOI: 10.1016/j.spinee.2023.06.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Spine Journal, 2023-10. Verfasst von Vera Francisco und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Research INCLIVA and Endocrinology and Nutrition Service, University Clinic Hospital of Valencia, Calle Menéndez y Pelayo nº4, 46…. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Intervertebral Disc, Annulus Fibrosus, Nucleus Pulposus. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: European Cooperation in Science and Technology, Ministerio de Universidades, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas.
Abstract (Originalsprache)
BACKGROUND CONTEXT: Intervertebral disc degeneration (IVDD) is an incurable, specific treatment-orphan disease with an increasing burden worldwide. Although great efforts have been made to develop new regenerative therapies, their clinical success is limited. PURPOSE: Characterize the metabolomic and gene expression changes underpinning human disc degeneration. This study also aimed to disclose new molecular targets for developing and optimizing novel biological approaches for IVDD. STUDY DESIGN: Intervertebral disc cells were obtained from IVDD patients undergoing circumferential arthrodesis surgery or from healthy subjects. Mimicking the harmful microenvironment of degenerated discs, cells isolated from the nucleus pulposus (NP) and annulus fibrosus (AF) were exposed to the proinflammatory cytokine IL-1β and the adipokine leptin. The metabolomic signature and molecular profile of human disc cells were unraveled for the first time. METHODS: The metabolomic and lipidomic profiles of IVDD and healthy disc cells were analyzed by high-performance liquid chromatography-mass spectrometry (UHPLC-MS). Gene expression was investigated by SYBR green-based quantitative real-time RT-PCR. Altered metabolites and gene expression were documented. RESULTS: Lipidomic analysis revealed decreased levels of triacylglycerols (TG), diacylglycerol (DG), fatty acids (FA), phosphatidylcholine (PC), lysophosphatidylinositols (LPI) and sphingomyelin (SM), and increased levels of bile acids (BA) and ceramides, likely promoting disc cell metabolism changing from glycolysis to fatty acid oxidation and following cell death. The gene expression profile of disc cells suggests LCN2 and LEAP2/GHRL as promising molecular therapeutic targets for disc degeneration and demonstrates the expression of genes related to inflammation (NOS2, COX2, IL-6, IL-8, IL-1β, and TNF-α) or encoding adipokines (PGRN, NAMPT, NUCB2, SERPINE2, and RARRES2), matrix metalloproteinases (MMP9 and MMP13), and vascular adhesion molecules (VCAM1). CONCLUSIONS: Altogether, the presented results disclose the NP and AF cell biology changes from healthy to degenerated discs, allowing the identification of promising molecular therapeutic targets for intervertebral disc degeneration. CLINICAL SIGNIFICANCE: Our results are relevant to improving current biological-based strategies aiming to repair IVD by restoring cellular lipid metabolites as well as adipokines homeostasis. Ultimately, our results will be valuable for successful, long-lasting relief of painful IVDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Health Research INCLIVA and Endocrinology and Nutrition Service, University Clinic Hospital of Valencia, Calle Menéndez y Pelayo nº4, 46010 Valencia, Spain; SERGAS (Servizo Galego de Saude) and IDIS (Instit…
- SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), NEIRID Lab (Neuroendocrine Interactions in Rheumatology and Inflammatory Diseases), Research Laboratory 9, Santiago Universit…
- University Clinic Hospital of Valencia and Department of Pharmacology, Faculty of Medicine and Odontology, Institute of Health Research INCLIVA, University of Valencia, Calle Menéndez y Pelayo, nº4, 46010 Valencia, Spai…
- Institute of Health Research INCLIVA and Endocrinology and Nutrition Service, University Clinic Hospital of Valencia, Calle Menéndez y Pelayo nº4, 46010 Valencia, Spain; CIBERDEM-Spanish Biomedical Research Centre in Di…
- SERGAS (Servizo Galego de Saude) and IDIS (Instituto de Investigación Sanitaria de Santiago), Molecular and Cellular Cardiology Lab, Research Laboratory 7, Santiago University Clinical Hospital, Tr.ª da Choupana s/n, 15…
Förderung
- European Cooperation in Science and Technology
- Ministerio de Universidades
- Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
- European Commission
- European Regional Development Fund
- Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
- Centro de Investigación Biomédica en Red de Cáncer
- Ministerio de Ciencia e Innovación
Zitieren
APA
Francisco, V., Ait Eldjoudi, D., González-Rodríguez, M., Ruiz-Fernández, C., Cordero-Barreal, A., Marques, P., Sanz, M. J., Real, J. T., Lago, F., Pino, J., Farrag, Y., & Gualillo, O. (2023). Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells. The Spine Journal, 23(10), 1549-1562. https://doi.org/10.1016/j.spinee.2023.06.005
Vancouver
Francisco V, Ait Eldjoudi D, González-Rodríguez M, Ruiz-Fernández C, Cordero-Barreal A, Marques P, et al. Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells. The Spine Journal. 2023;23(10):1549-1562. doi:10.1016/j.spinee.2023.06.005
BibTeX
@article{Francisco2023,
author = {Francisco, Vera and Ait Eldjoudi, Djedjiga and González-Rodríguez, María and Ruiz-Fernández, Clara and Cordero-Barreal, Alfonso and Marques, Patrice and Sanz, Maria Jesus and Real, José T and Lago, Francisca and Pino, Jesus and Farrag, Yousof and Gualillo, Oreste},
title = {Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells},
journal = {The Spine Journal},
year = {2023},
volume = {23},
number = {10},
pages = {1549--1562},
doi = {10.1016/j.spinee.2023.06.005}
}
EUVIMED